Cynthia Aki
Publications by Year
Research Areas
Chemical Synthesis and Analysis, Chemokine receptors and signaling, Asymmetric Synthesis and Catalysis, Multicomponent Synthesis of Heterocycles, Chemical Synthesis and Reactions
Most-Cited Works
- → Discovery of 2-Hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123): A Potent, Orally Bioavailable CXCR2/CXCR1 Receptor Antagonist(2006)113 cited
- → C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonists(2007)43 cited
- → Synthesis and structure–activity relationships of heteroaryl substituted-3,4-diamino-3-cyclobut-3-ene-1,2-dione CXCR2/CXCR1 receptor antagonists(2008)17 cited
- → Synthesis of functionalized hydroxy-thiophene motifs as amido- and sulfonamido-phenol bioisosteres(2009)12 cited
- → A two-step procedure for the preparation of mono-protected bis-N-heterocyclic alkyl ether systems(2006)8 cited
- → Diaminocyclobutenediones as potent and orally bioavailable CXCR2 receptor antagonists: SAR in the phenolic amide region(2009)8 cited
- → Exploring the Role of Bromine at C(10) of (+)-4-[2-[4-(8-Chloro-3,10-dibromo- 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11(R)-yl)-1-piperidinyl]-2- oxoethyl]-1-piperidinecarboxamide (Sch-66336): The Discovery of Indolocycloheptapyridine Inhibitors of Farnesyl Protein Transferase(2002)7 cited
- → Corrigendum to “A two-step procedure for the preparation of mono-protected bis-N-heterocyclic alkyl ether systems”(2007)1 cited
- → Inhibiting Fornesyl Protein Transferase with Sch-66336: Potentially a Selective, Noncytotoxic Therapy for Human Cancer(2001)
- → A Two‐Step Procedure for the Preparation of Mono‐Protected Bis‐N‐heterocyclic Alkyl Ether Systems.(2007)